Summary
This Mendelian randomisation study used genetic instruments to clarify the independent causal roles of different circulating lipoprotein lipids in coronary heart disease aetiology. Analysing genome-wide association data from over 393,000 UK Biobank participants and 184,305 CHD cases/controls, the authors identified hundreds of genetic variants associated with LDL cholesterol, triglycerides, HDL cholesterol, and apolipoproteins B and A-I. The work provides genetic evidence for the relative causal importance of specific lipid fractions in CHD risk, informing understanding of cardiovascular disease mechanisms.
UK applicability
As the study was conducted in the United Kingdom using UK Biobank data, the genetic associations and causal estimates are directly applicable to UK populations. The findings may inform lipid-based cardiovascular risk stratification and therapeutic targeting in UK clinical practice and public health guidance.
Key measures
Odds ratios for coronary heart disease per 1-standard-deviation-higher lipoprotein lipid trait; number of SNPs associated with each lipid trait at P < 5 × 10⁻⁸; lipid and apolipoprotein concentrations in UK Biobank participants
Outcomes reported
The study used multivariable Mendelian randomisation to determine the causal relationships between circulating lipoprotein lipid traits (LDL cholesterol, triglycerides, HDL cholesterol, apolipoprotein B and A-I) and coronary heart disease risk. It identified genetic variants associated with lipid concentrations and evaluated their independent causal effects on CHD.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.